COHANCE · Healthcare
The board meets on 6 Nov 2026 to approve the results. This page fills in when the numbers are filed.
| Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹231 cr | ₹220 cr | ₹253 cr | ₹488 cr | ₹604 cr | ₹676 cr | ₹840 cr | ₹549 cr | ₹556 cr | ₹545 cr | ₹619 cr | ₹422 cr |
| YoY | — | — | — | +40% | +161% | +207% | +232% | +13% | −8% | −19% | −26% | −23% |
| EBITDA margin | 42.4% | 30.0% | 28.9% | 25.6% | 33.9% | 35.1% | 27.3% | 20.4% | 21.8% | 17.4% | 16.0% | 0.2% |
| Other income, % of PBT | 19% | 22% | 24% | 18% | 9% | 11% | −2% | 10% | 19% | 2% | −90% | — |
| Exceptional items | — | — | — | — | — | — | — | — | — | — | — | — |
| Tax rate | 25% | 29% | 25% | 27% | 21% | 25% | 27% | 26% | 21% | 29% | 58% | — |
| Net profit | ₹80.0 cr | ₹47.0 cr | ₹53.0 cr | ₹75.0 cr | ₹138 cr | ₹153 cr | ₹117 cr | ₹46.0 cr | ₹66.0 cr | ₹29.0 cr | ₹8.0 cr | −₹45.0 cr |
| YoY | — | — | — | −38% | +73% | +226% | +121% | −39% | −52% | −81% | −93% | −198% |
| Core profit YoY | — | — | — | −45% | +86% | +259% | +206% | −32% | −57% | −78% | −77% | −196% |
| EPS | ₹3.13 | ₹1.84 | ₹2.10 | ₹2.96 | ₹5.44 | ₹6.01 | ₹4.73 | ₹1.28 | ₹1.94 | ₹0.96 | ₹0.51 | −₹0.63 |
| Flags | · | · | · | 1 | 1 | ✓ | ✓ | 1 | 1 | 1 | 1 | 2 |
Each quarter is read with the same rules. Balance-sheet and cash checks run on half-year and annual quarters; filing-read checks run where a read exists.
Numbers as filed with the exchanges, read by rules. Every flag is a question with its source, not an accusation. FinMinutes is a financial data and analytics platform; nothing here is a recommendation to buy, sell or hold any security. How each check works.